Description
This panel analyses 72 genes associated with the reported increased risk in at least one study of one or more of the following hereditary cancers: breast, colorectal, endometrial, gastric, melanoma, ovarian, pancreatic, prostate, renal, skin, thyroid, and uterine.
The test can be used to confirm the presence of a genetic variant in already diagnosed cancer patients, and to inform the presence of an increased risk to develop cancer from the same variant in the immediate relatives of the cancer patient.
It is also suitable for individuals with a family history of cancer to identify their risk of developing the disease due to an inherited genetic variant